Because very aggressive growth properties of MYCN-induced neuroblastomas in zebrafish with loss of both alleles of nf1a (See Figure 2) are attributable to aberrant activation of RAS-MAPK signaling (see Figures 6 and 7), we evaluated the importance of MEK inhibition for the treatment of these tumors. Here, MAP2K7 is linked to neuroblastoma.